Table 1

Steady-state activation and inactivation parameters of HERG and KvLQT1/IsK currents in the absence and presence of verapamil, bepridil, and mibefradil

ActivationInactivation
CellsV0.5kCellsV0.5k
mV mV
HERG
 Control11−13.9  ± 1.18.4  ± 0.311−26.1  ± 4.617.8  ± 0.6
 Verapamil (1 μM)−21.9  ± 2.11-a 7.9  ± 0.3−48.4  ± 4.51-a 20.2  ± 0.7
 Control10−12.1  ± 2.18.1  ± 0.410−32.7  ± 6.316.7  ± 1.1
 Bepridil (0.5 μM)−20.2  ± 2.51-a 7.2  ± 0.4−54.3  ± 7.11-a 18.9  ± 1.2
 Control10−13.1  ± 1.28.4  ± 0.68−35.9  ± 5.216.0  ± 0.7
 Mibefradil (1 μM)−21.1  ± 1.31-a 7.7  ± 0.2−60.0  ± 4.31-a 17.5  ± 0.8
KvLQT1/IsK
 Control832.0  ± 3.626.2  ± 1.5
 Bepridil (10 μM)34.3  ± 5.521.8  ± 1.7
 Control620.0  ± 3.523.1  ± 2.0
 Mibefradil (10 μM)23.3  ± 1.120.3  ± 1.2
  • Data are expressed as mean ± standard error. Values of V0.5 and k were obtained with a Boltzmann function.

  • 1-a Statistically significant difference (p < 0.05) compared with control.